New Drug Applications

Cassiopea Announces FDA Submission of New Drug Application for Clascoterone Cream 1%

7 years ago
by David Miller
958 Views
Written by David Miller

Lainate, Italy – August 20, 2019 – Cassiopea SpA (SIX: SKIN), a specialty pharmaceutical company developing and commercializing prescription drugs with novel mechanisms of action (MOA) to address long-standing and essential dermatological…Original Article

You may also like

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

View all posts
[mwai_chat window="true" fullscreen="true"]